Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with131I-anti-CD20 antibody and stem cell rescue

✍ Scribed by Karin Hohloch; Carsten Oliver Sahlmann; Vijai J. Lakhani; Gerald Wulf; Bertram Glaß; Justin Hasenkamp; Johannes Meller; Joachim Riggert; Lorenz Trümper; Frank Griesinger

• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 233 KB
• Volume: 90
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-011-1199-y